Skip to the content
  • Suomeksi
  • About us
    • > Our role
    • > BoD and management
  • For pharma sector
    • > Research archive
  • Newsfeed
  • Contacts
  • Suomeksi

Category: Blog

  • In category BlogPosted on 03.02.2023

    Conducting successful clinical trials for influenza vaccines

    Finding more effective vaccines for the constantly moving target of influenza with longer-term immunity is a cause worth pursuing. For example, the mRNA technology opens opportunities to develop and manufacture effective vaccines closer to the flu season, with a better match to the circulating viruses. But what are successful clinical trials made of? Mika Rämet, […]

  • In category BlogPosted on 24.10.2022

    Vaccine development thrives – Finland offers unique possibilities

    Finland has strong expertise in high-quality vaccine research based on decades of experience. In addition, exceptional national data resources increase the attractiveness of Finland for international research investments. When the overall impact of vaccines is studied on a large scale, in addition to clinical trials aimed at obtaining a license for marketing authorization, important evidence […]

  • About us
    • Our role
    • BoD and management
  • For pharma sector
    • Research archive
  • Newsfeed
  • Contacts

FVR - Finnish Vaccine Research
Peltokatu 26, 33100 Tampere, Finland
info@fvr.fi Business ID FI32566594

  • About cookies

© Copyrights 2022 FVR – Finnish Vaccine Research